Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
International Journal of Molecular Sciences
|
September 27, 2019
The <i>CXCR4-CXCL12</i>-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro
Katrin Pansy, Julia Feichtinger, Barbara Ehall, et al.
Ejhaem
|
September 2, 2025
Chemokine Receptor Profiles as Predictors of Survival and Early Progression in Follicular Lymphoma
Antonella Zupo, Katrin Pansy, Lukas Gaksch, et al.
Molecular and Cellular Biology
|
August 15, 2003
Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation
Chenguang Wang, Nagarajan Pattabiraman, Jian Nian Zhou, et al.
Transplantation and Cellular Therapy
|
July 2, 2026
Impact of Disease Biology and Bridging Strategy on Outcomes After CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma
Irene Strassl, Alexander Nikoloudis, Lina Zoe Ruesing, et al.
Nature Communications
|
July 17, 2015
D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2
An-Ping Lin, Saman Abbas, Sang-Woo Kim, et al.
Blood
|
December 20, 2014
Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study
Andreas Tiede, Robert Klamroth, Rüdiger E Scharf, et al.
Hemasphere
|
April 25, 2025
Comparing functional and genomic-based precision medicine in blood cancer patients
Lukas Kazianka, Alexander Pichler, Christiane Agreiter, et al.
International Journal of Molecular Sciences
|
July 27, 2022
Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter's Trans-Formed DLBCL and Germinal Center B-Cells
Barbara Uhl, Katharina T Prochazka, Katrin Pansy, et al.
ACS Pharmacology & Translational Science
|
November 21, 2022
Selective Inhibition of Bruton's Tyrosine Kinase by a Designed Covalent Ligand Leads to Potent Therapeutic Efficacy in Blood Cancers Relative to Clinically Used Inhibitors
Bárbara B Sousa, Cátia Rebelo de Almeida, Ana F Barahona, et al.
Cancer Discovery
|
October 12, 2021
Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders
Christoph Kornauth, Tea Pemovska, Gregory I Vladimer, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
International Journal of Molecular Sciences
|
September 27, 2019
The <i>CXCR4-CXCL12</i>-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro
Katrin Pansy, Julia Feichtinger, Barbara Ehall, et al.
Ejhaem
|
September 2, 2025
Chemokine Receptor Profiles as Predictors of Survival and Early Progression in Follicular Lymphoma
Antonella Zupo, Katrin Pansy, Lukas Gaksch, et al.
Molecular and Cellular Biology
|
August 15, 2003
Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation
Chenguang Wang, Nagarajan Pattabiraman, Jian Nian Zhou, et al.
Transplantation and Cellular Therapy
|
July 2, 2026
Impact of Disease Biology and Bridging Strategy on Outcomes After CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma
Irene Strassl, Alexander Nikoloudis, Lina Zoe Ruesing, et al.
Nature Communications
|
July 17, 2015
D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2
An-Ping Lin, Saman Abbas, Sang-Woo Kim, et al.
Blood
|
December 20, 2014
Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study
Andreas Tiede, Robert Klamroth, Rüdiger E Scharf, et al.
Hemasphere
|
April 25, 2025
Comparing functional and genomic-based precision medicine in blood cancer patients
Lukas Kazianka, Alexander Pichler, Christiane Agreiter, et al.
International Journal of Molecular Sciences
|
July 27, 2022
Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter's Trans-Formed DLBCL and Germinal Center B-Cells
Barbara Uhl, Katharina T Prochazka, Katrin Pansy, et al.
ACS Pharmacology & Translational Science
|
November 21, 2022
Selective Inhibition of Bruton's Tyrosine Kinase by a Designed Covalent Ligand Leads to Potent Therapeutic Efficacy in Blood Cancers Relative to Clinically Used Inhibitors
Bárbara B Sousa, Cátia Rebelo de Almeida, Ana F Barahona, et al.
Cancer Discovery
|
October 12, 2021
Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders
Christoph Kornauth, Tea Pemovska, Gregory I Vladimer, et al.
Page
of 9